Trade Summary

1 week ago, Fitzgerald Meghan, serving as Dir at Roivant Sciences Ltd. (ROIV), sold 70,000 shares at $27.45 per share, for a total transaction value of $1,921,500.00. Following this transaction, Fitzgerald Meghan now holds 42,963 shares of ROIV.

This sale represents a 62.00% decrease in Fitzgerald Meghan's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, March 26, 2026 and publicly disclosed via SEC Form 4 filing on Monday, March 30, 2026, 4 days after the trade was made.

Roivant Sciences Ltd. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.